References
- Heading R C. Definitions of dyspepsia. Scand J Gastroenterol 1991; 26: 1–6, Suppl 182
- Talley N J. Drug treatment of functional dyspepsia. Scand J Gastroenterol 1991; 26: 47–60, Suppl 182
- Harasawa S, Miwa T. Chronic gastritis and gastric function. Rinsho Shokaki Naika 1987; 2: 107–14
- Bekhti A, Rutgeerts L. Domperidone in the treatment of functional dyspepsia in patients with delayed gastric emptying. Postgrad Med J 1979; 55: 30–2, Suppl 1
- McCallum R W, Prakash C, Campoli-Richards D M. Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. Drugs 1988; 36: 652–81
- Schuurkes J AJ, Helsen L FM, Ghoos E CR. Stimulation of gastroduodenal motor activity: dopaminergic and cholinergic modulation. Drug Devel Res 1986; 8: 233–41
- Reyntjens A, Verlinden M, De Coster R. Clinical pharmacological evidence for cisapride's lack of antidopaminergic or direct cholinergic properties. Current Ther Res 1984; 36: 1045–52
- Verlinden M, Reyntjens A, Schuermans V. Safety profile of cisapride. Progress in the treatment of gastrointestinal motility disorders: the role of cisapride, A G Johnson, G Lux. Excerpta Medica, Amsterdam 1988; 30–6
- Baldi F, Bianchi-Porro G, Dobrilla G. Placebo-controlled study of the effect of cisapride on the lesions and symptoms of reflux oesophagitis. Progress in the treatment of gastrointestinal motility disorders: the role of cisapride, A G Johnson, G Lux. Excerpta Medica, Amsterdam 1988; 60–9
- Camilleri M, Brown M L, Malagelada J R. Impaired transit of chyme in chronic intestinal pseudo-obstruction. Correction by cisapride. Gastroenterology 1986; 91: 619–26
- François I, DeNutte N. Cisapride in the treatment of functional non-ulcer dyspepsia. A double-blind, placebo-controlled, crossover trial. Digestion 1986; 34: 151
- Huettemann W. Cisapride in esophagitis. A placebo-controlled trial. Digestion 1986; 34: 143
- Horowitz M, Maddox A, Harding P E. Effect of cisapride on gastric and esophageal emptying in insulin dependent diabetes mellitus. Gastroenterology 1987; 92: 1899–907
- Reboa G, Arnulfo G, Frascio M. Colon motility and coloanal reflexes in chronic idiopathic constipation. Effects of a novel enterokinetic agent cisapride. Eur J Clin Pharmacol 1984; 26: 745–8
- Rösch W. Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial. Scand J Gastroenterol 1987; 22: 161–4
- Ceccatelli P, Janssens J, Vantrappen G. Cisapride restores the decreased lower esophageal sphincter pressure in reflux patients. Gut 1988; 29: 631–5
- Weiser H F, Holscher A, Zimmerman T. Effect of cisapride and metoclopramide on the lower esophageal motility pressure. A pressure and pH-metric study. Digestion 1986; 34: 142
- Wienbeck M, Cuder-Wiesinger E, Berges W. Comparative study on cisapride's versus metoclopramide's effect on esophageal motility. Digestion 1986; 34: 141
- Chen H T, Wiley J, Owyang C. Mechanism of action of cisapride: evidence for regional difference in the gastrointestinal tract. Gastroenterology 1986; 90: 1370
- Ghigliani M, Iantorno G, Vásquez S, Varela A. Acute effect of the gastrokinetics cisapride and metoclopramide on the gastric emptying function in patients with the early satiety syndrome. Acta Gastroenterol Latinoam 1987; 17: 43–50
- Jian R, Ducrot F, Piedeloup C. Measurement of gastric emptying in dyspeptic patients; effect of a new gastrokinetic agent (cisapride). Gut 1985; 26: 352–8
- Schuurkes J AJ, Van Nueten J M, Van Daele P GH. Motor-stimulating properties of cisapride on isolated gastrointestinal preparation of the guinea pig. J Pharmac Exp Ther 1985; 234: 775–83
- Urbain J LC, Siegel J A, Debie N C, Pauwels S P. Effect of cisapride on gastric emptying in dyspeptic patients. Dig Dis Sci 1988; 33: 779–83
- Deruyttere M, Milo R, Creytens G. Therapy of chronic functional dyspepsia: multicenter crossover study of cisapride and placebo. Progr Med 1987; 43: 61–8, Suppl 1
- Reyntjens A. Therapeutic doses of cisapride in the treatment of chronic functional dyspepsia. Progress in the treatment of gastrointestinal motility disorders: the role of cisapride, A G Johnson, G Lux. Excerpta Medica, Amsterdam 1988; 151–7
- Malagelada J R. When and how to investigate the dyspeptic patient. Scand J Gastroenterol 1991; 26: 70–4, Suppl 182
- Nyrén O. Therapeutic trial in dyspepsia: its role in the primary care setting. Scand J Gastroenterol 1991; 26: 61–9, Suppl 182